Oragenics

Oragenics unveils automated intranasal device for treating concussed patients (NYSE:OGEN)

Oragenics (NYSE:OGEN) on Thursday said that it had completed the development of its prototype of its automated intranasal device that would help in treating concussed patients. The company added that a phase II study is being designed to analyze the effectiveness of ONP-002 on blood biomarkers and patient-reported outcomes ofContinue Reading

Oragenics shares fall on proposed securities offering

In: Finance

Oragenics (NYSE:OGEN) said on Monday it was proposing to offer and sell shares of its common stock (or pre-funded warrants) in a public offering. Shares of OGEN fell 6.02% in extended trading. The company said that all the securities to be sold in the offering are to be offered by Oragenics. OGEN plans to use the offering to fund theContinue Reading

Oragenics unveils automated intranasal device for treating concussed patients (NYSE:OGEN)

Oragenics shares fall on proposed securities offering

Integrate dynamic web content in your generative AI application using a web search API and Amazon Bedrock Agents | Amazon Web Services

Build a generative AI assistant to enhance employee experience using Amazon Q Business | Amazon Web Services